IP Library Assignment 056159/0064
Patent Assignment
Reel/Frame 056159/0064

Assignment of Assignor's Interest

Recorded: 2021-05-06 Pages: 9
Assignor
KOTA BIOTHERAPEUTICS, LLC
Executed: 2021-05-05
Assignee
THE INVENTION SCIENCE FUND II, LLC
3150 139TH AVENUE SE, BELLEVUE, WASHINGTON, 98005
Covered Properties (16)
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including an Exogenously Incorporated Nucleic Acid Expressing an Exogenous Membrane Immunoglobulin Reactive to a First Antigen and Including an Endogenous Gene Expressing an Endogenous Secreted Immunoglobulin Reactive to a Second Antigen
Patent: 9,175,072 →
Application: 13/374,351 →
Publication: US 2013/0164784
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including at Least One Endogenous Gene Expressing at Least One Endogenous Membrane Immunoglobulin Reactive to a First Antigen and Including at Least One Exogenously Incorporated Nucleic Acid Expressing at Least One Exogenous Secreted Immunoglobulin Reactive to a Second Antigen
Patent: 8,962,315 →
Application: 13/374,353 →
Publication: US 2013/0164277
Compositions, Methods, and Computer Systems Related to Making and Administering Modified T Cells
Patent: 9,587,237 →
Application: 13/804,224 →
Publication: US 2014/0271579
Compositions, Methods, and Computer Systems Related to Making and Administering Modified T Cells
Patent: 9,499,855 →
Application: 13/827,960 →
Publication: US 2014/0271581
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including an Exogenously Incorporated Nucleic Acid Expressing an Exogenous Membrane Immunoglobulin Reactive to a First Antigen and Including an Endogenous Gene Expressing an Endogenous Secreted Immunoglobulin Reactive to a Second Antigen
Patent: 9,512,213 →
Application: 14/549,685 →
Publication: US 2015/0203572
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including an Exogenously Incorporated Nucleic Acid Expressing an Exogenous Membrane Immunoglobulin Reactive to a First Antigen and Including an Endogenous Gene Expressing an Endogenous Secreted I
Patent: 9,637,540 →
Application: 14/549,726 →
Publication: US 2015/0079605
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including an Exogenously Incorporated Nucleic Acid Expressing an Exogenous Membrane Immunoglobulin Reactive to a First Antigen and Including an Endogenous Gene Expressing an Endogenous Secreted I
Patent: 9,845,351 →
Application: 14/549,763 →
Publication: US 2015/0147749
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including at Least One Endogenous Gene Expressing at Least One Endogenous Membrane Immunoglobulin Reactive to a First Antigen and Including at Least One Exogenously Incorporated Nucleic Acid Expr
Patent: 9,468,655 →
Application: 14/623,722 →
Publication: US 2015/0210773
Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including at Least One Endogenous Gene Expressing at Least One Endogenous Membrane Immunoglobulin Reactive to a First Antigen and Including at Least One Exogenously Incorporated Nucleic Acid Expressing at Least One Exogenous Secreted Immunoglobulin Reactive to a Second Antigen
Patent: 9,901,598 →
Application: 14/623,759 →
Publication: US 2015/0283177
Compositions and Methods Including Cytotoxic B Lymphocyte Cell Line Expressing Exogenous Membrane Immunoglobulin Different from Secreted Immunoglobulin
Application: 15/178,715 →
Publication: US 2016/0355783
Compositions, Methods, and Computer Systems Related to Making and Administering Modified T Cells
Patent: 9,662,354 →
Application: 15/290,043 →
Publication: US 2017/0027987
Compositions and Methods for Modified B Cells Expressing Reassigned Biological Agents
Application: 15/924,898 →
Publication: US 2018/0215817
Compositions, Methods, and Computer Systems Related to Making and Administering Modified T Cells
Application: 16/205,556 →
Publication: US 2019/0091263
Compositions and Methods Including Cytotoxic B Lymphocyte Cell Line Expressing Exogenous Membrane Immunoglobulin Different from Secreted Immunoglobulin
Application: 16/256,222 →
Publication: US 2019/0153388
Compositions and Methods for Modified B Cells Expressing Reassigned Biological Agents
Application: 16/523,664 →
Publication: US 2019/0352385
Compositions and Methods for Modified B Cells Expressing Reassigned Biological Agents
Application: 16/994,837 →
Publication: US 2021/0095010
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 13, 2012
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.
To: ELWHA LLC
Reel/Frame 027855/0763 →
Assignment of Assignor's Interest Mar 13, 2012
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.
To: ELWHA LLC
Reel/Frame 027854/0193 →
Assignment of Assignor's Interest Nov 11, 2013
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.; MCKNIGHT, GARY L.
To: ELWHA LLC
Reel/Frame 031577/0307 →
Assignment of Assignor's Interest Nov 11, 2013
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.; MCKNIGHT, GARY L.
To: ELWHA LLC
Reel/Frame 031576/0133 →
Assignment of Assignor's Interest Apr 6, 2015
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.
To: ELWHA LLC
Reel/Frame 035339/0238 →
Assignment of Assignor's Interest Apr 13, 2015
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.
To: ELWHA LLC
Reel/Frame 035393/0524 →
Assignment of Assignor's Interest Apr 13, 2015
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.
To: ELWHA LLC
Reel/Frame 035393/0346 →
Assignment of Assignor's Interest Aug 18, 2015
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.
To: ELWHA LLC
Reel/Frame 036346/0594 →
Assignment of Assignor's Interest Aug 18, 2015
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.
To: ELWHA LLC
Reel/Frame 036345/0948 →
Assignment of Assignor's Interest Oct 17, 2016
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.; MCKNIGHT, GARY L.
To: ELWHA LLC
Reel/Frame 040029/0687 →
Assignment of Assignor's Interest Jun 8, 2018
From: HYDE, RODERICK A.; KINDSVOGEL, WAYNE R.; MCKNIGHT, GARY L.
To: ELWHA LLC
Reel/Frame 046031/0524 →
Assignment of Assignor's Interest Aug 29, 2019
From: ELWHA LLC
To: THE INVENTION SCIENCE FUND II, LLC
Reel/Frame 050216/0254 →
Assignment of Assignor's Interest Nov 13, 2019
From: THE INVENTION SCIENCE FUND II, LLC
To: KOTA BIOTHERAPEUTICS, LLC
Reel/Frame 050995/0470 →
Assignment of Assignor's Interest Jan 29, 2020
From: THE INVENTION SCIENCE FUND II, LLC
To: KOTA BIOTHERAPEUTICS, LLC
Reel/Frame 051661/0108 →